Leukaemia requires a centre where haematology, modern laboratory diagnostics (cytogenetics, molecular panels) and the bone marrow transplantation programme are brought together under one roof — because the strategy can change at any time. Anadolu’s Haematology-Oncology centre, one of the most experienced in the region, provides exactly this continuity.
Acute leukaemias require treatment to start urgently: the hospital admits these patients through a fast-track procedure, responding to documents within 24 to 48 hours.
Treatment methods at Anadolu
Induction and consolidation chemotherapy
Modern protocols delivered with support in sterile units for AML and ALL; the plan is adjusted according to the molecular response (MRD).
Targeted treatment
FLT3, IDH, BCR-ABL (TKIs in chronic myeloid leukaemia) and other targeted options — chosen according to the genetic profile of the leukaemia, which is determined as standard.
Allogeneic bone marrow transplantation
In high-risk and relapsed leukaemias, a transplant is performed from a family donor, an unrelated donor or a haploidentical donor; more than 3,000 transplants have been performed at the centre.
Immunotherapy
In ALL, bispecific antibodies and conjugates; for refractory disease, new options at the decision of the medical board.
Supportive care
Sterile rooms, transfusion support and infection control — an infrastructure that allows intensive protocols to be applied safely.
Why international patients choose Anadolu
- Affiliation with Johns Hopkins Medicine — shared clinical protocols with one of the largest medical centres in the United States.
- JCI, ESMO and OECI accreditations — internationally recognised quality and patient safety.
- Multidisciplinary tumour boards — your treatment plan is decided not by a single doctor but by a team of specialists.
- Support in English — a coordinator and an interpreter at every step, from your first enquiry to discharge.
- A transparent cost estimate before you travel — you know the estimated cost of treatment in advance.
- Practical assistance — our team assists with travel and, where needed, visa formalities.
Specialist doctors
Zafer Gülbaş
Professor of Internal Medicine and Haematology
Haematology-Oncology and Bone Marrow Transplantation
Savaş Kansoy
Professor
Paediatric OncologyHow to start your treatment
Send your records
Reports, scans and test results — via the form, by email or WhatsApp.
The doctor’s opinion
A specialist will review your case free of charge within 48 hours.
Plan and cost estimate
You will receive the treatment plan and its estimated cost — before you travel.
Arrival and treatment
Transfers, accommodation and an interpreter — everything is arranged by the hospital.
Frequently asked questions — leukaemia
How quickly can you admit a patient with acute leukaemia?
Through a fast-track procedure: a response to documents within 24 to 48 hours and admission within a few days. In acute leukaemias, time is critical.
When is a transplant needed?
In cases of high-risk genetic profiles, an insufficient response to induction (MRD+) or relapse. The decision is made by the board on the basis of a full work-up.
Who can be a donor?
A brother or sister (a 25% chance of a match), an unrelated donor from a registry, or a haploidentical donor (parent or child) — modern techniques make half-matched transplants successful too.
How long does treatment take?
Induction requires a hospital stay of 4 to 6 weeks; with consolidation, the full programme extends over several months. Transplantation: 4 to 6 weeks at the hospital followed by outpatient follow-up.
Does chronic leukaemia (CLL/CML) need to be treated immediately?
CML is treated with TKI tablets with excellent results; early-stage CLL often only requires monitoring. Send your test results — the haematologist will assess whether the time has come to treat.
Request a treatment plan and cost estimate
Free: a specialist will review your records within 48 hours.